| Mr William Edward Thawley, RP | |
|
322 N 7th St., Allentown, PA 18104 | |
| (610) 867-3239 | |
| Not Available |
| Full Name | Mr William Edward Thawley |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 322 N 7th St., Allentown, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750824264 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP026711L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr William Edward Thawley, RP 9108 Briarwood Dr, Bethlehem, PA 18020 Ph: (610) 867-3239 | Mr William Edward Thawley, RP 322 N 7th St., Allentown, PA 18104 Ph: (610) 867-3239 |
News Archive
Using a combination of "Jeopardy," "Saturday Night Live" and a famous Discovery Channel show called MythBusters, patient advocates and researchers at Vanderbilt Ingram Cancer Center presented "Mythbusters: Cancer Research in Jeopardy" to their community in an effort to increase awareness of cancer research, particularly clinical trials.
The shift from living in jungle huts to cities has dramatically changed human exposure to certain microbes, which could have implications for healthy immune function, according to a study led by researchers from NYU Langone Medical Center and published online Feb. 12, 2016 in Science Advances.
A Cochrane review of the accuracy of skin cancer diagnostics has found that visual inspection of suspicious lesions is insufficient to ensure an accurate diagnosis.
Among rescue and recovery workers exposed to the dust, debris, and fumes following the World Trade Center terrorist attack, there was an increased incidence of prostate and thyroid cancers and multiple myeloma, although it is not clear how big a factor medical screening and non-WTC risk factors contributed to these increases, according to a study in the December 19 issue of JAMA.
Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the European Commission has granted European market authorization for the medicinal product teduglutide (trade name in Europe: Revestive) as a once-daily treatment for adult patients with short bowel syndrome.
› Verified 4 days ago
Jacinta M Hudak, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1855 S 5th St, Allentown, PA 18103 Phone: 610-791-7796 | |
Mr. Michael Francis Mastroianni, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5829 Tilghman St, Allentown, PA 18104 Phone: 610-398-3228 Fax: 610-530-1815 | |
Bhavini Patel Miller, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 361 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-821-7999 Fax: 610-821-8191 | |
Umesh Patel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1579 Kaitlyn Rd, Allentown, PA 18103 Phone: 484-221-9650 | |
Elizabeth Shober, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8887 | |
Mrs. Tammy Ann Hill, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6520 Stonegate Dr, Suite 100, Allentown, PA 18106 Phone: 610-794-5380 Fax: 610-794-5415 | |
Nicole Yeager, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 912 Airport Center Dr, Allentown, PA 18109 Phone: 610-573-5711 Fax: 610-573-5711 |